Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study Group.

A A Fauser; B Duclos; A Chemaissani; A Del Favero; F Cognetti; E Diaz-Rubio; H Cortes-Funes; P F Conte; H Dressler

doi:10.1016/0959-8049(96)00132-3

Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study Group.

Identifier:nobleid.org/w1/20260515/DFDBAC88

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFDBAC88.svg?ark=w1%2F20260515%2FDFDBAC88)](https://nobleid.org/work/w1/20260515/DFDBAC88)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study Group.

Identifier:nobleid.org/w1/20260515/DFDBAC88

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFDBAC88.svg?ark=w1%2F20260515%2FDFDBAC88)](https://nobleid.org/work/w1/20260515/DFDBAC88)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work